Mike Ralston, CEO of Blencowe Resources, explains the significance of the MSP for Orom-Cross. Watch the interview here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just looking at recent years accounts, there has been very little money incoming into the company which I see has resulted in multiple share placings. Stalicla appears to be the only potential source of income from what I can see at present but there appears to be a serious stumbling block with this deal as $500k was due to be paid when phase 1b was completed, which it was a whole year ago but no money received.
Is there any other sources of income that I’m not aware of? If not how will TCF survive once the current reserves run out next year?
I’m sorry to say that this share is in grave danger of going bust within a year unless there is a big turn around in fortune.
Grants and private funding were discussed about an hour in and at the end during the Q&A parts of the recent Research and Development Update
THERACRYF PLC - Research and Development Update
https://youtu.be/a3bYtaY2URw?si=jnB6XUxkPZW1OIgu
Grants and private funding? I think it’s wishful thinking, grants may help fund trials but can’t see it covering wages, rent and rates. As for private funding, I can’t see who would lend TCF money if they have no money incoming to cover the loan repayments, whilst no one is going to just give millions to a plc out of the kindness of their heart.
It shouldn’t be down to grants and private funding, TCF have been in business for 10 years, they should have sn income stream by now. I’ve never heard of a company run with no income before.
Being on AIM investors should expect dilution via placings until revenue, merger or acquisition news.
Evgen could have placed at 20p years ago and again at 4p when the Stalicla deal news was announced, investors would have moaned but probably traded or averaged down but Evgen/ TCF would have a better cash position.
Huw hasn't played the AIM game well imo, TBH he's a flucking idiot imo
Blaming the low MCAP on interest rates and high fuel costs !
The reason why the MCAP is so low is because Huw has failed to deliver, end of
Rant at Huw aside, I'm optimistic that we could see Yuge gains at some point.
Could be due to Stalicla, Cancer treatment news or perhaps due to the recently acquired assets.
So I'm not rage selling because I believe there's a min 10X hiding behind a not great CEO (imo)
Unfortunately any ten bagger at 0.6p will still keep many here underwater. It would be a start though.
Think the mm's are having a laugh buying millions at 0.6p from somebody and now attempting to offload at 0.72p+
I really believed this share was going to set me up nicely when I bought in just after the Stalicla deal was announced in Oct 2022. I had renewed hope 6 months ago when EVG issued a dispute notice to Stalicla about the missing $500k payment. Now I think this share is completely done, I don’t see any income at all between now and next Spring when it looks like the money will run out.
If you’re holding here I would recommend just holding out as I’m guessing most people are down so much that it’s not worth selling now.
William Black took that 2.5 mil yesterday
Sometimes it doesn't hurt to say what if .
So ignor the noise and hold x
Is there any £ to made from chronos or whatever it was they bought?
Given Huws ability to deliver I'd say it's unlikely
There are some huge MCAP companies in this area so there is always the 'What If' factor ;-)
Good question about is this new company they paid a million pounds for (correct me if I’m wrong there) going to generate any income. I’m not sure I’ve read about any income stream. It was obvious they bought this as they had run out of work on SFX-01, you don’t hear much about that any more. Didn’t they produce millions of tablets of it? They’ll be out of date soon. I think Huw had a stake in this company TCF bought, if he did he’ll be enjoying his windfall.
CJ,
To be honest your last comment is incorrect on so many levels it's actually not worth attempting to correct.
If you are going to keep posting on here at least try to provide some accurate information ;-)
DS, just point out one of the things I said that is incorrect and I will try find the information to back up my point.
Ok they try this one:
"Didn’t they produce millions of tablets of it?"
Feel free to find information on the number of tablets and the expiry date of any tablets produced:
"They’ll be out of date soon."
I found this in full year results June 2023:
MANUFACTURING PROGRAMME
Following a competitive process, a new supplier of the key intermediate material for the synthesis of SFX-01 was contracted. The new manufacturer has extensive facilities and capabilities. Circa 25kg of product has been successfully manufactured in good time and at a competitive price. A further 25kg is expected in H2. This will be sufficient for clinical requirements in the foreseeable future.
That’s 50kg of SFX-01. 50kg = 50,000 grams.
There are 1000 mg = 1 gram. Therefore they have 50 million mgs of product. The tablets are usually about 50mg based on most medication. Therefore 50m mg divided by 50 mg tablets = 1m tablets.
What is incorrect about that?
Good reply ;-)
However, that references the key intermediate material for the synthesis of SFX-01. It doesn't say they manufactured millions of capsules.
"I think Huw had a stake in this company TCF bought, if he did he’ll be enjoying his windfall."
https://find-and-update.company-information.service.gov.uk/company/06838479/filing-history?page=1
It probably wasn’t a million but I do remember in 2023 the loss for the year was over £4m and was significantly higher and they did state this was due to:
The increase in operating loss compared with 2022 reflects escalation of manufacturing activity and commencement and completion of the clinical work in the Phase I/Ib trial, less £442k in revenue from the Stalicla deal.
As for the shelf life of the tablets, I can’t find that but most medications I’ve used have a shelf life of 24 months. But I’m only making an assumption on that.
Track Your Investments
Register for FREE